**Question:** Which of the following for pain control in terminally ill cancer patients?

A. Opioids
B. Non-steroidal anti-inflammatory drugs (NSAIDs)
C. Local anesthetics
D. Benzodiazepines

**Core Concept:** Pain control in terminally ill cancer patients primarily relies on pharmacological interventions targeting the underlying neuropathic and nociceptive mechanisms.

**Why the Correct Answer is Right:** Opioids are the most effective drugs for pain management in cancer patients due to their strong affinity for mu-opioid receptors, which are predominantly involved in pain transmission and modulation. They work by reducing the perception of pain and increasing pain tolerance.

**Why Each Wrong Option is Incorrect:**

B. Non-steroidal anti-inflammatory drugs (NSAIDs) are primarily used to treat inflammation and reduce fever but have limited efficacy in pain control due to their lack of direct interaction with pain receptors.
C. Local anesthetics primarily target pain of peripheral nerve origin, but are not effective for central neuropathic pain, which is common in terminally ill cancer patients.
D. Benzodiazepines are primarily used for anxiety, sedation, and muscle relaxation, with minimal effect on pain control.

**Clinical Pearl:** In clinical practice, a multimodal approach is often employed for pain control in terminally ill cancer patients. This involves using a combination of opioids, NSAIDs, and local anesthetics to target different aspects of pain pathways. However, the core principle remains the use of opioids like morphine, fentanyl, or hydromorphone, which are the cornerstone of pain management in this patient population.

**Correct Answer:** A. Opioids (e.g., morphine, fentanyl, or hydromorphone) are the primary choice for pain control in terminally ill cancer patients due to their potent affinity for mu-opioid receptors and effective modulation of pain perception and tolerance.